Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I

NCT00004333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Tyrosinemia, Type I

Interventions

DRUG: NTBC

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]